• Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly 

      Bernabéu, Ignacio; Fajardo, Carmen; Marazuela, Mónica; Cordido, Fernando; Venegas, Eva; Pablos Velasco, Pedro de; Piedrola Maroto, Gonzalo; Olvera Márquez, María del Pilar; Pavón de Paz, Isabel; Carvalho, Davide; Romero, Carmen; De la Cruz, Guillermo; Álvarez Escolá, Cristina (Springer, 2020-07-28)
      [Abstract] Purpose. Recent data indicate that extended dosing intervals (EDIs) with lanreotide autogel 120 mg are effective and well-received among patients with acromegaly who have achieved biochemical control with monthly ...
    • Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study 

      Cámara, Rosa; Venegas, Eva; García-Arnés, Juan Antonio; Cordido, Fernando; Aller, J.; Samaniego, M. Luz; Mir, Nuria; Sánchez-Cenizo, Laura (Springer, 2019-02-13)
      [Abstract] PURPOSE: The burden of chronic daily subcutaneous administration of pegvisomant on adherence has not been previously studied. This study was aimed to determine the adherence to pegvisomant treatment in acromegaly ...